Tempus AI Cash on Hand 2023-2024 | TEM

Tempus AI cash on hand from 2023 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  • Tempus AI cash on hand for the quarter ending December 31, 2024 was $0.448B, a 126.88% increase year-over-year.
  • Tempus AI cash on hand for 2024 was $0.448B, a 126.88% increase from 2023.
  • Tempus AI cash on hand for 2023 was $0.198B, a 34.78% decline from 2022.
  • Tempus AI cash on hand for 2022 was $0.303B, a 0% decline from .
Tempus AI Annual Cash on Hand
(Millions of US $)
2024 $448
2023 $198
2022 $303
Tempus AI Quarterly Cash on Hand
(Millions of US $)
2024-12-31 $448
2024-09-30 $466
2024-06-30 $490
2024-03-31 $95
2023-12-31 $198
2023-09-30
2023-06-30
2023-03-31
2022-12-31 $303
Sector Industry Market Cap Revenue
Medical Medical Information Systems $10.954B $0.693B
Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $36.709B 54.09
Hims & Hers Health (HIMS) United States $11.210B 183.25
Inspire Medical Systems (INSP) United States $5.532B 107.78
IRhythm Technologies (IRTC) United States $3.734B 0.00
Privia Health (PRVA) United States $2.941B 245.10
Enovis (ENOV) United States $2.475B 16.49
Clover Health Investments (CLOV) United States $2.095B 0.00
Azenta (AZTA) United States $2.083B 96.98
Omnicell (OMCL) United States $1.845B 40.23
Schrodinger (SDGR) United States $1.580B 0.00
Phreesia (PHR) United States $1.577B 0.00
10x Genomics (TXG) United States $1.381B 0.00
Butterfly Network (BFLY) United States $0.859B 0.00
Fulgent Genetics (FLGT) United States $0.512B 0.00
Standard BioTools (LAB) United States $0.495B 0.00
Talkspace (TALK) United States $0.481B 285.00
TruBridge (TBRG) United States $0.423B 123.26
Nyxoah SA (NYXH) Belgium $0.353B 0.00
Pulmonx (LUNG) United States $0.352B 0.00
Health Catalyst (HCAT) United States $0.305B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.257B 0.00
American Well (AMWL) United States $0.174B 0.00
EUDA Health Holdings (EUDA) Singapore $0.097B 0.00
MDxHealth SA (MDXH) Belgium $0.085B 0.00
P3 Health Partners (PIII) United States $0.075B 0.00
111 (YI) China $0.072B 0.00
CareCloud (CCLD) United States $0.054B 0.00
HeartBeam (BEAT) United States $0.054B 0.00
Outset Medical (OM) United States $0.044B 0.00
Zepp Health (ZEPP) China $0.042B 0.00
SHL Telemedicine (SHLT) Israel $0.038B 0.00
Zhongchao (ZCMD) China $0.034B 0.00
Movano (MOVE) United States $0.032B 0.00
Bullfrog AI Holdings (BFRG) United States $0.023B 0.00
Streamline Health Solutions (STRM) United States $0.015B 0.00
MSP Recovery (MSPR) United States $0.015B 0.00
Precipio (PRPO) United States $0.014B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.013B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.010B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Syra Health (SYRA) United States $0.005B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00